News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mistral Pharma Inc. Signs an In-Licensing Deal With Grupo Uriach


10/4/2007 12:24:16 PM

MONTREAL, QUEBEC--(Marketwire - October 04, 2007) - Mistral Pharma Inc. (TSX VENTURE: MIP) ("Mistral") today announced that it has signed a licensing agreement with J. Uriach & CIA, S.A. ("Uriach"), a Grupo Uriach company, for the marketing and distribution of Rupatadine for the Canadian market. Mistral intends to file a new drug submission for TAMALIS™ (Rupatadine) with Health Canada in the first half of 2008.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES